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Background: Direct antagonists of native antimicrobial peptide (AMP) sequences are unknown.
Results: Complementary antagonistic sequences can co-fold with AMPs into functionally inert assemblies.
Conclusion: Antagonists act as anti-AMPs.
Significance: The findings offer a molecular rationale for anti-AMP responses with potential implications for antimicrobial
resistance.
Antimicrobial or host defense peptides are innate immune
regulators found in all multicellular organisms. Many of them
fold into membrane-bound -helices and function by causing
cell wall disruption in microorganisms. Herein we probe the
possibility and functional implications of antimicrobial antago-
nism mediated by complementary coiled-coil interactions
between antimicrobial peptides and de novo designed antago-
nists: anti-antimicrobial peptides. Using sequences from native
helical families such as cathelicidins, cecropins, and magainins
we demonstrate that designed antagonists can co-foldwith anti-
microbial peptides into functionally inert helical oligomers. The
properties and function of the resulting assemblies were studied
in solution, membrane environments, and in bacterial culture
by a combination of chiroptical and solid-state NMR spectros-
copies, microscopy, bioassays, and molecular dynamics simula-
tions. The findings offer a molecular rationale for anti-antimi-
crobial responses with potential implications for antimicrobial
resistance.
Intermolecular recognition by peptides is a critical aspect of
regulatory processes at cellular interfaces (1). Native systems
ranging from viral fusion proteins (2) and SNARE complexes
(3) to membrane skeletal networks (4) and harbor domains of
enteric pathogens (5) rely on specific -helical coiled coils to
maintain interfacial contacts in a highly cooperative manner.
Amphipathic helical monomers can be designed to incorporate
alternative interfaces into such assemblies, thereby disrupting
regulatory processes (6). By contrast, amphipathic antimicro-
bial helices bind to microbial membranes without a priori
requirements for specific assemblies (7). Given their sequence
similarities with coiled coils, antimicrobial peptides may be
challenged by co-assembly with antagonistic helices, a propo-
sition that has so far been unexplored. Thus, the overall aim of
this study is to explore the hypothesis that antimicrobial activ-
ity in peptides can be effectively neutralized by the formation of
inert coiled-coil complexes.
Coiled-coil sequences show heptad repeats of hydrophobic
and polar residues (usually designated abcdefg), in which a and
d form hydrophobic interfaces (8). To form contiguous inter-
faces the a/d patterns of corresponding helices must be in reg-
ister, which is prevented by the average spacing of hydrophobic
residues along a coiled-coil sequence being 3.5 residues. This is
less than one complete turn (3.6 residues) of a monomeric
-helix (9). To rectify this discrepancy a/d patterns impose a
slight left-handed twist enabling left-handed helix-crossing
angles in the coiled-coil bundle, which permits, but does not
guarantee, stable coiled coils. Further stabilization is required
through complementary electrostatic interactions at e and g
sites of successive heptads between partner strands (i.e. g-e
interactions: g of one heptad and e of the following heptad
on the other helix) (Fig. 1) (8, 9). Therefore, in assigning
coiled-coil patterns in antimicrobial sequences it is neces-
sary to consider hydrophobic a/d pairs in conjunction with
charged e/g pairs.
Antimicrobial peptides (AMPs)2 are cationic amphipathic
structures that fold and oligomerize in anionic phospholipid
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membranes (7). By this convention, antagonistic sequences are
anionic amphipathic helices that remain unfolded in solution
and in membrane environments but fold upon binding to cati-
onic AMPs (Fig. 1). The strength and stability of this binding
depend on helical propensity and persistence length. An anti-
microbial sequence can comprise up to 50 amino acid residues
(7, 10; see also antimicrobial sequences database at the bbcm
Web site at the University of Trieste, Italy), and most helical
AMPs contain 20–35 residues which should be sufficient for
coiled-coil formation (11). However, and importantly, native
antimicrobial helices often incorporate helix-disrupting motifs
to facilitate membrane insertion. Common examples include
glycine zipper G(X)nG motifs, where X is any residue and n 
3–6 (12, 13). Length correlations between these motifs and
antimicrobial peptides are not obvious. For instance, bom-
binins prefer n 3 as do membrane proteins that incorporate
glycine zippers for transmembrane helix dimerization, whereas
cecropins, defensins, and magainins tend to have variable n, a
strategy also used by proteins to specify phosphate binding and
domain folding (14–19). Given these dependences and prefer-
ences for longer coiled coils in membrane proteins (2–5) it was
appropriate to probe one sequence having a relatively long and
uninterrupted helical stretch and another longer sequence con-
taining G(X)nG motifs. A cathelicidin, bovine myeloid antimi-
crobial peptide-27 (b27) (20), and cecropin B (cB), originally
isolated from the cecropia moth Hyalophora cecropia (21) met
the requirements (Fig. 1).
EXPERIMENTAL PROCEDURES
Peptide Synthesis—All peptides were synthesized on a Liberty
microwave peptide synthesizer (CEM Corporation) using stan-
dard solid phase Fmoc (N-(9-fluorenyl)methoxycarbonyl) proto-
cols on Rink amide-4-methylbenzhydrylamine resins with
HCTU/DIPEA as coupling reagents. Peptides were purified by
semipreparative RP-HPLC on a JASCO HPLC system (model
PU-980; Tokyo, Japan) and confirmed by MALDI-TOF mass
FIGURE 1. Peptide design. A, cathelicidin type: bovinemyeloid antimicrobial peptide-27 (b27) and anti-b27. B, cecropin type: native cecropin B (cB), cecropin
B template (cBt), and anti-cecropin B template (anti-cBt). Linear sequences (top) and configured onto helical wheels (bottom) aremonomeric with 3.6 residues
(left) and coiled-coil with 3.5 residues (right) per turn. Antimicrobial peptides and antagonists are shown in blue and red, respectively. Mutations in cBt are in
black, and key residues in helix-disruptingmotifs are underlined. Three overlappingG(X)nGmotifs are highlightedbyhorizontal brackets.Double-headed arrows
denote electrostatic e-g interactions.
Anti-antimicrobial Peptides
JULY 12, 2013•VOLUME 288•NUMBER 28 JOURNAL OF BIOLOGICAL CHEMISTRY 20163
 at Edinburgh University Library on August 12, 2013http://www.jbc.org/Downloaded from 
spectrometry (Bruker Daltonics) with -cyano-4-hydroxycin-
namic acid as the matrix.
MS [MH]: b27, m/z 3282.2 (calc.), 3283.2 (found); anti-
b27, 3138.3 (calc.), 3139.3 (found); cB,m/z 3834.5 (calc.), 3836.0
(found); cBt, m/z 3968.1 (calc.), 3969.1 (found); anti-cBt, m/z
3843.4 (calc.), 3843.4 (found); m2, m/z 2465.9 (calc.), 2467.0
(found); m2t, m/z 2526.1 (calc.), 2526.1 (found); m2t2, m/z
2555.3 (calc.), 2556.2 (found); anti-m2, m/z 2529.8 (calc.),
2529.8 (found); anti-m2t2, m/z 2560.9 (calc.), 2562.0 (found).
[MNa] and [MK] were also found.
High Performance Liquid Chromatography—Analytical and
semipreparative gradient RP-HPLC was performed on a
JASCO HPLC system using Vydac C18 analytical (5 m) and
semipreparative (5 m) columns. Both analytical and semi-
preparative runs used a 10–60% B gradient over 50 min at 1
ml/min and 4.5 ml/min, respectively, with detection at 230 and
220 nm. Buffer A was 5% and buffer B was 95% aqueous
CH3CN, 0.1% TFA.
Lipid Vesicle Preparation—The lipids, 1,2-dilauroylphos-
phatidylcholine (DLPC) and 1,2-dilauroyl-sn-glycero-3-phos-
pho-(1-rac-glycerol) (DLPG), 75%/25% (w:w) used for lipo-
some construction were from Avanti Polar Lipids. The lipids
were weighted up, dissolved in chloroform-methanol (2:1, v:v),
dried under a nitrogen stream, and placed under vacuum over-
night. The resulting film was hydrated to 10 mg/ml total lipid
concentration in 10 mM phosphate buffer, pH 7.4. The suspen-
sion was then extensively vortexed, sonicated (30 °C), and
extruded using a hand-held extruder (Avanti Polar Lipids) (15
times, polycarbonate filter, 0.05 m) to give a clear solution
containing small unilamellar vesicles, which were analyzed (50
nm) by photon correlation spectroscopy.
Photon Correlation Spectroscopy—Vesicles were resus-
pended to a final concentration of 1 mg/ml and were analyzed
on a Zetasizer Nano (ZEN3600,Malvern Instruments,Worces-
tershire, UK). Dynamic light scattering batch measurements
were carried out in a low volume disposable cuvette at 25 °C.
Hydrodynamic radii were obtained through the fitting of auto-
correlation data using the manufacture’s software, Dispersion
Technology Software (DTS version 5.10).
Circular Dichroism Spectroscopy—All CD spectra were
recorded on a JASCO J-810 spectropolarimeter fitted with a
Peltier temperature controller. Allmeasurementswere taken in
ellipticities in millidegrees and converted to molar ellipticities
([], deg cm2 dmol1) by normalizing for the concentration of
peptide bonds. Aqueous peptide solutions (300 l, at a given
concentration) were prepared in filtered (0.22 m) 10 mM
phosphate buffer, pH 7.4. CD spectra recorded in the presence
of synthetic membranes are for lipid:peptide molar ratio of
100:1. CD titrations were performed at 20 °C by titrating anti-
cBt (177.5 M) into cBt (30 M) to achieve anti-cBt/cBt molar
ratios from 0.1 to 2.
Linear Dichroism Spectroscopy—Solution-phase flow linear
dichroism spectroscopy was performed on a JASCO-810 spec-
tropolarimeter using a photo elastic modulator 1/2 wave plate,
and a micro-volume quartz Couette flow cell with 0.25 mm
annular gap and quartz capillaries (all from Kromatec Ltd.).
Molecular alignmentwas achieved through the constant flowof
the sample solution between two coaxial cylinders: a stationary
quartz rod and a rotating cylindrical capillary. Linear dichroism
(LD) spectra were acquired with laminar flow obtained by
maintaining the rotation speed at 3000 rpm and processed by
subtracting nonrotating base-line spectra. LD spectra recorded
in the presence of synthetic membranes, DLPC and DLPC:
DLPG (3:1), were prepared at a lipid:peptide molar ratio of
100:1 (2 mM total lipid, 20 M peptide).
FTIR Spectroscopy—All FTIR spectra were collected using a
Tensor-37 series FTIR spectrophotometer with a BioATR II
unit (Bruker Optics) as the sampling platform with a photovol-
taicMCTdetector and a BrukerOptics work station, whichwas
equipped with OPUS software. Aqueous samples of very low
volume (15 l, 50–130 M) were placed in a circular sampling
area of radius 2 mm with a path length of 6 m. This multire-
flection ATR accessory is based on a dual crystal technology,
which has an upper silicon crystal and a hemispherical zinc-
selenide (ZnSe) lower crystal that does not come into contact
with the sample. The temperature of the sample was main-
tained at 20 °C by means of flow connectors to a circulating
water bath. This accessory was purged continuously through-
out the experiment with dry nitrogen via telescopic inserts that
seals the optical path inside the spectrometer sample compart-
ment. All FTIR spectra were collected with resolution 4 cm1,
scanner velocity 20 kHz, 256 scans, phase resolution 32, and
zero filling factor 4.
Analytical Ultracentrifugation—Sedimentation equilibrium
experiments for anti-cBt and cBt peptides and their equimolar
mixture were carried out at 20 °C in a Beckman Optima XL-I
analytical ultracentrifuge fitted with absorbance and interfer-
ence optics. Sedimentation equilibrium curves were measured
by interference optics in the 1.2-cm path length cells. 100-l
samples of 100Mpeptides, individually and as equimolarmix-
tures buffered to pH 7 with 20 mM potassium phosphate, were
used. Buffer density was taken as 1.0007 mg/ml, and samples
were equilibrated for 24 h at rotor speeds of 30,000, 37,000 and
50,000 rpm. The data were fitted using routines in Origin (Ori-
gin Lab). The average partial specific volumes for the peptides
were calculated from the amino acid sequences and were 0.73
ml/mg for all samples.
Isothermal Titration Calorimetry—Measurements were ob-
tained using a Microcal VP-isothermal titration calorimeter
and a calorimetric cell (initial volume 1.46 ml) with a 260-s
equilibration time and a 120-s initial delay after each addition.
The titrations were performed at 20 °C with stirring until no
further enthalpy changes were observed. Binding isotherms
were recorded for cBt (30 M) following the injection of anti-
cBt (2 l aliquots, 1.4 mM) into the cell. The observed heats
were corrected for dilution effects by titrating peptide solu-
tions, as appropriate, into the buffer and using the heat of last
injections due to negligible differences between the first and last
injections. All the datawere corrected for the volume of the added
titrant and analyzed by proprietary software (Microcal Origin 7)
using a one-site binding model to allow for the determination of
associationconstants (Ka), changes inenthalpy (H) andenthropy
(S). Each experiment was performed in triplicate.
Solid-state NMR—DMPC-d54 and DMPG were purchased
fromAvanti Polar Lipids and used without further purification.
A 3:1 (molar ratio) of DMPC:DMPG (8 mg of total lipid) was
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solubilized in a 2:1 mixture (v/v) of chloroform and methanol
and dried under a stream of N2 gas to generate a thin film. The
lipid film was subsequently rehydrated with 20 mM HEPES
buffer (containing deuterium-depletedH2O and peptide) at pH
7 to a final volume of 30l. 1 mg/ml stock solutions of cecropin
mutant and blocker peptides were prepared in deuterium-de-
pleted HEPES buffer at pH 7 and were added to the hydrated
lipid to give a final total lipid:peptide molar ratio of 25:1. In
samples in which the cecropin mutant and blocker were both
present, the individual stock peptide solutions were combined
before being diluted and added to the lipid film for rehydration.
Static ssNMR experiments were carried out on a Varian Infini-
typlus 500-MHz spectrometer equipped with a 4-mm MAS
HXY probe at 30 °C. All samples were prepared with total lipid
concentrations of 10mg/ml in 20mMpH7HEPES buffer. Static
2H ssNMR spectra were acquired at 76.8 MHz using a quadru-
polar echo sequence with a recycle delay of 0.5 s. 200,000 scans
were collected, and 2H pulse lengths of 4 s were used.
Molecular Dynamics Simulations—Molecular dynamics simu-
lations of the cecropin assembly inserted in aqueous solutionwere
performed inGROMACS (v4.5.5) using the AMBER99SB-ILDN
force field with 150 mM concentration of sodium and chloride
molecules for charge neutralization. AMBER99SB-ILDN was
chosen following testing of four force fields, and correctly
reproduced phenomena were observed in the primary mono-
meric spectra whereas other force fields showed helical bias.
Monomeric structures were simulated for 50 ns in the NPT
ensemble following energy minimization, 200-ps equilibration
in the NVT ensemble, and 200-ps equilibration in the NPT
ensemble. The dimer structure was run for 100 ns with 200ips
equilibration steps in the NVT and NPT ensembles, both with
and without peptide position restraints. These extra steps
allowed for relaxation of the solvent and the dimer in each
ensemble. The initial helical configuration was obtained using
the XPlor-NIH structure determination algorithm. In detail,
the temperature was coupled using a velocity-rescaling ther-
mostat (coupling time 0.1 ps) with separate peptide and solvent
coupling groups. Pressure coupling was isotropic and achieved
through a Parrinello-Rahman coupling scheme (coupling time
2.0 ps).
Bond lengths were constrained using the LINCS algorithm.
The TIP3P water model was used, and a time step of 2 fs was
used throughout. Coulomb and van der Waals forces were
treated by a twin range cut-off scheme, with short range elec-
trostatics experiencing a cutoff of 1 nm and long range by par-
ticle-mesh Ewald with grid spacing of 0.12 nm. Pair-lists were
updated every five steps.
Minimum Inhibitory Concentration (MIC) Assay—MICs
were determined by broth microdilution on Pseudomonas
aeruginosa ATCC 27853, Escherichia coli K12, Staphylococcus
aureus ATCC 25723, Micrococcus luteus NCIMB 13267, and
Bacillus subtilisATCC 6633 according to the Clinical and Lab-
oratory Standards Institute. Typically, 100 l of 0.5–1  106
cfu/ml of each bacterium in Mueller-Hinton medium broth
(Oxoid) was incubated in 96-well microtiter plates with 100 l
of serial 2-fold dilutions of the peptides (from 100 to 0 M) at
37 °C on a three-dimensional orbital shaker. The absorbance
was measured after peptide addition at 600 nm using a Victor 2
plate reader (PerkinElmer Life Sciences). MICs were defined as
the lowest peptide concentration after 24 h at 37 °C. All tests
were done in triplicate.
Stain-dead Antimicrobial Assay—S. aureus (ATCC 25723)
culture (1 ml) was centrifuged to give a cell pellet, which was
washed twice with 10 mM phosphate buffer, pH 7.4, before
being reconstituted in phosphate buffer to giveA600 nm 0.008.
1 ml of the solution was dispensed in a 2-well glass chamber
(LabTek)with diluted (1/500) propidium iodide (1mg/ml, from
Invitrogen). The chambers with surface-settled bacteria (60
min) were mounted on a confocal microscope (Olympus)
equipped with an incubation chamber at 37 °C. Propidium
iodide fluorescence emission was monitored at 625 nm for 60
min (three frames/min) using an appropriate filter after the
addition of peptide (1 ml). Recorded images (XYZ) were ana-
lyzed using Fiji software to plot the number of fluorescent
(stain-dead) cells as a function of time.
Hemolysis Assay—Hemolysis was determined by incubating
10% (v/v) suspension of human erythrocytes with peptides.
Erythrocytes were rinsed four times in 10 mM PBS, pH 7.2, by
repeated centrifugation and resuspension (3 min at 3000  g).
Erythrocytes were incubated at room temperature for 1 h in
either deionized water (fully hemolysed control), PBS, or with
peptide in PBS. After centrifugation at 10,000 g for 5min, the
supernatant was separated from the pellet and the absorbance
measured at 550 nm. Absorbance of the suspension treated
with deionized water defined complete hemolysis. The values
below correspond to the percentage of hemolysis at tested con-
centrations. All tests were done in triplicate.
Gram Stain Assays—20 l of a bacterium culture was dis-
pensed onto a glass slide and spread well. The slide was swiftly
passed through a Bunsen flame to dry and fix cells before stain-
ing. The fixed bacteria were first covered in crystal violet
(0.25%) for 30 s followed by washing with water (distilled, fil-
tered 0.22 m) until all of the excess stain was washed off, and
then with iodine (1.0%) for 2 min before washing with a mini-
mum amount of acetone needed to rinse off the iodine color.
The cells were counterstained with safranin (0.5%) for 30 s,
washed with water, and dried by a Bunsen flame. The obtained
slides were viewed under a Leica DMLB fluorescent micro-
scope. The images were obtained at100 magnification under
oil and analyzed by ImageJ.
RESULTS
CathelicidinAssemblyDesign—b27 consists of 27 amino acid
residueswith one glycine at each terminus (20). TheC-terminal
heptad of the peptide is predominantly hydrophobic and con-
tains a PXXP motif, which is believed to promote membrane
insertion (22). A largerN-terminal stretch has three incomplete
coiled-coil heptads starting with a charged arginine at g fol-
lowed by putative a/d and g/epatterns. An antagonist sequence,
anti-b27, was designed to match these patterns in a parallel
arrangement. a and d positions were occupied by core-stabiliz-
ing combinations of phenylalanine and leucine residues to favor
low oligomers while promoting cooperative folding (23–25).
Negatively charged glutamates were used in g and e positions of
anti-b27 to pair corresponding g, e lysines and arginines in
b27. The remaining b, c, and f sites weremade neutral polar and
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alanine residues. The PXXPmotif in the antagonist was deemed
redundant and was replaced to stabilize coiled-coil formation.
Fig. 1A summarizes the design.
Cathelicidin Assembly Folding—Consistent with the design,
the peptides did not fold individually in aqueous solutions at
micromolar concentrations. Circular dichroism (CD) spectra
were characteristic of randomcoil or disordered conformations
(Fig. 2A). Similarly, none of the peptides folded in the presence
of zwitterionic unilamellar vesicles whose composition mimics
that of mammalian membranes (supplemental Fig. S1). In con-
trast, CD spectra for equimolar peptide mixtures showed
appreciable helical signals indicative of coiled-coil formation
(Fig. 2A). The behavior of the peptides in anionic unilamellar
vesicles, which mimicked microbial membranes, was consis-
tent with the observations. Unlike anti-b27, which remained
disordered, b27 underwent a coil-helix transition suggesting
membrane binding (Fig. 2B).
The helix content in both cases did not exceed 35% (supple-
mental Fig. S1). The percentage of -helix was estimated using
the equation: 100([]222  3000)/33,000 (26). However, the
thermal denaturation of pairmixtures gave sigmoidal unfolding
curves indicative of cooperatively folded structures (Fig. 2C).
Low temperature CD and FTIR spectra recorded before and
after thermal unfolding revealed almost complete reversibility
of folding (supplemental Fig. S1). The first derivatives of the
unfolding curves comprised several overlapping transitions
with two clear cut-offs of transition midpoints (Tm) at approx-
imately 37 °C and 70 °C, with the higher Tm becoming more
pronounced at higher concentrations (Fig. 2D). The transitions
were broadly within the biokinetic temperature ranges. How-
ever, the lower cut-off remained apparent at all concentrations
and was dominating at lower concentrations (Fig. 2D).
Although b27 was strongly antimicrobial (Table 1) the effect of
the antagonist on the activity of b27 could not bemeasuredwith
certainty (results not shown). Therefore, anti-b27-b27 interac-
tions were deemed insufficiently stable under physiological
conditions. The lack of stability can be attributed to that g-e
interactions available in b27 can support the assembly of only
FIGURE 2. Peptide folding probed by CD spectroscopy. A, CD spectra for b27 (red line), anti-b27 (blue line), and anti-b27:b27 (black line) in 10mM phosphate
buffer. B, CD spectra for b27 (red line) and anti-b27 (blue line) in anionic membranes. C and D, thermal unfolding curves (C) and their first derivatives for
anti-b27:b27 (D) as a function of temperature at 222 nm. E, CD spectra for cB (green line), cBt (red line), anti-cBt (blue line), anti-cBt:cB (magenta line), and
anti-cBt:cBt (black line) in 10mMphosphate buffer. F, CD spectra for cB (green line), cBt (red line), and anti-cBt (blue line) in anionicmembranes.G andH, thermal
unfolding curves (G) and their first derivatives (H) for anti-cBt:cBt as a function of temperature at 222 nm. CD spectra are for 30 M concentration of each
peptide, pH 7.4, room temperature. Thermal unfolding curves are for 15 M (red line), 30 M (black line), and 50 M (blue line) concentration of each peptide.
Lipid-peptide ratio for CD spectra in anionic membranes was 100:1.
TABLE 1
Biological activity of peptides
Peptide
Minimum inhibitory concentration (MIC)
HE (LC50)aE. coli (K12)
P. aeruginosa
(ATCC27853)
B. subtilis
(ATCC6633)
S. aureus
(ATCC6538)
M. luteus
(NCIMB 13267)
M M M M M M
b27 3.13 0.43 4.51 1.56 0.78 0.01 	100 0.74 0.33 		250
Anti-b27 	200 	200 	200 	200 	200 		250
cB 0.62 0.01 1.56 0.01 50.7 0.10 	100 0.46 0.20 		250
cBt 1.28 0.04 1.55 0.01 6.33 0.12 25.9 0.06 0.36 0.10 		250
Anti-cBt 	200 	200 	200 	200 	200 		250
a Human erythrocytes, 50% cell death compared with untreated cells, 1–9% at 250 M.
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two combined heptads, which falls short of a stable coiled coil
formed by three contiguous heptads (Fig. 1A) (11). The longer
cB sequence was thus probed.
Cecropin Assembly Design—cB comprises 35 amino acid res-
idues and three G(X)nGmotifs, which in principle can span five
canonical coiled-coil repeats. However, all three G(X)nGmotifs
form a contiguous stretch starting in the second heptad from
the N terminus which makes the assigning of contiguous
coiled-coil patterns problematic. Searches using coiled-coil
prediction algorithms (Paircoil2, COILS, Multicoil), albeit
biased toward stand-alone sequences, did not give any apparent
pattern either. Therefore, selective point mutations were
allowed.
The central G(X)4GP motif and the tryptophan residue,
important for activity (27), were kept in the sequence. The
N-terminal lysine was assigned to the first g position. This
ensured minimum mutations by placing isoleucines and leu-
cines in a and d and by swapping hydrophobic and polar resi-
dues in g and a to enable contiguous a-d/e-g pairs (23–25). A
singleAla3Lysmutation at an epositionwas adapted to enable
a continuous network of electrostatic interhelical interactions,
whereas aGlu3Glnmutation at a b position excluded an intra-
helical i, i4 electrostatic interaction. This completes a cB tem-
plate, cBt. Similar to the anti-b27, anti-cBt was designed tomir-
ror thea-d/e-g arrangements in cBt.Glutamateswere used at all
e and g sites, whereas isoleucines and leucines occupied a and d
sites. The G(X)4GP was simplified to G(X)5P. This stretch is
functionally irrelevant for anti-cBt, which is meant to be bio-
logically inactive, but structurally it is sufficient to prevent the
sequence of such length to fold autonomously. In the resulting
anti-cBt:cBt arrangement all five heptads of cBt contribute to
the binding with anti-cBt with the number of e-g pairs being
nearly doubled compared with b27 (Fig. 1B).
Cecropin Assembly Folding—The CD spectra of the pair in
aqueous solutions revealed 20% increases in helicity (26) versus
those recorded for anti-b27:b27 (Fig. 2, A and E, and supple-
mental Fig. S1). Comparable helical signals were recorded for
cBt and cB in anionic membranes (Fig. 2F). None of the pep-
tides folded in zwitterionic membranes (supplemental Fig. S1).
CD spectra for individual peptides and the equimolar mixtures
of cB with anti-cBt in solution as well as anti-cBt in anionic
membranes were characteristic of random coils (Fig. 2, E and
F). CD titrations performed by adding anti-cBt into the buff-
ered cBt, which was kept at a constant concentration, provided
quantitative information of coiled-coil interactions. The CD
values (millidegrees at 222 nm) showed saturation after reach-
ing an equimolar anti-cBt:cBt ratio (n  1) allowing thus the
stoichiometry of the complex being calculated from the titra-
tion curve as 1:1 (Fig. 3A). Sedimentation equilibrium data,
which fitted an analysis that assumed a single ideal species,
returned aMr of 7148 (93% confidence limits of 6766 and 7527)
for the 1:1 anti-cBt:cBt mixture, which was close to that
expected for an anti-cBt:cBt dimer (7811), versus a Mr of 3508
(3328, 3691) for the monomeric anti-cBt (3843) (Fig. 3B). Fur-
ther evidence comes from isothermal titration calorimetry
experiments. Binding isotherms obtained for cBt titrated with
anti-cBt support endothermic binding characteristic of native
coiled-coil systems (28), and the integrated heats fitted into a
single site binding model gave a stoichiometry of 1:1 (n  0.8)
and a strong association (binding) constant (Ka) of 2.8 0.2
106 M1. The endothermic binding enthalpy (H) for this inter-
FIGURE 3.Stoichiometry of anti-cBt:cBt interactions.A, CDpoints recorded for 222 nmby titrating anti-cBt into cBt (30M). The intersectionof the lines fitted
on the titration curve indicates a1:1binding stoichiometry.B, sedimentationequilibriumanalysis. Experimental data (open circles)were collectedat 37,000 rpm
for a 100 M sample at 20 °C. The line is a calculated curve for an ideal dimer. C, isothermal titration calorimetry of the interactions. Heat absorbed (cal/s) for
each isotherm isplotted versus titration time (min) and showsendothermicbinding (toppanel). Integratedheats (kcal/mol) areplotted versusanti-cBt:cBtmolar
ratios (bottom panel).
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action was 9.7 kcal/mol with a favorable G of 7.8 kcal/mol
(Fig. 3C).
Consistent with the design, the results are comparable with
those for other native and designed coiled-coil systems (28–30)
and indicate that cB and cBt efficiently and selectively bind to
anionic membranes and anti-cBt bundles up with cBt. Collec-
tively, the data confirm cooperative and strong anti-cBt-cBt
interactions, which remain at equilibrium with cBt.
To gain a better insight into oligomerization we performed
molecular dynamics simulations using the Amber99SB-ILDN
force field (supplemental text) (31). The 20-ns simulations of
individual peptides revealed random conformations with no
further significant changes to the peptides observed into 50 ns
of simulations. Elements of helical structure in individual resi-
dues and short peptide stretches were present in both peptides
which can be accounted for by their high helical propensities
(Fig. 4, A and B, and supplemental Fig. S2). When visualized
together following an equilibration phase, anti-cBt and cBt
appeared to align in parallel supported by hydrophobic (a-d)
and charged (e-g) contacts (Fig. 4C). At initial configurations (0
ns) the C-terminal fragments and hinge regions proved to be
partly unfolded, but over 100 ns the assembly evolved into a
rigid -helical structure (Fig. 4D), which was consistent with
the secondary structure analysis of each residue using the
STRIDE secondary structure algorithm (supplemental Fig. S2).
The C-terminal fragments retained a degree of unfolding, sug-
gesting some fraying of the assembly. This arrangement was
maintained over 100 ns conforming to the formation of a stable
and cooperatively folded structure.
The findings were further supported by sigmoidal unfolding
curves of anti-cBt:cBt (Fig. 2G). The first derivatives of the
curves gave dominating transition midpoints at	60 °C, which
at higher concentrations increased to 	70 °C (Fig. 2H). The
obtained spectra had some structure suggesting partial unfold-
FIGURE4.Moleculardynamics simulationsof cecropinassembly.Secondary structure visualizationafter 50ns for cBt (A) andanti-cBt (B), and for anti-cBt:cBt
(C) at the initial configuration (0 ns) and after 100 ns (D).
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ing, consistent with the simulations, or -to- conformational
transitions. CD spectra recorded after the thermal denatur-
ation agreed with incomplete reversibility of folding, whereas
FTIR spectra recorded before and after thermal denaturation
showed nearly identical helical bands at 1650 cm1 and 1550
cm1, with no indication of a -sheet switch (1610–1625
cm1) (supplemental Fig. S1). CD spectroscopy can only reveal
averaged or relative changes in helicity corresponding tomixed
types of binding comprising membrane-bound antimicrobial
peptides and assembled coiled coils, both of which are associ-
ated with helix formation.
Further evidence for antagonist effects on antimicrobial pep-
tides may be ascertained from changes in membrane binding
monitored by LD spectroscopy. LD arises from differential
absorption of light linearly polarized parallel and perpendicular
to an orientation axis and thereby provides a convenient probe
of relative peptide orientation to the membrane surface (32).
LD spectra for cB and cBt in anionic membranes were similar
and showed positive and negative bands at approximately 200–
210 nm and 220–230 nm, respectively, which are characteristic
of -* and n-* electronic transitions of peptide helices lying
flat on membrane surfaces (33). This is consistent with the
proposed carpet-like mechanism of action for cB (34) and
indicates that cBt should retain this mode of action (Fig. 5A
and supplemental Fig. S3).
Negligible signals were recorded for anti-cBt in anionic
membranes (Fig. 5A and supplemental Fig. S3) and for all pep-
tides in zwitterionic membranes (supplemental Fig. S3). In the
presence of anti-cBt no absorption patterns could be identified,
suggesting interfering contributions from anti-cBt (Fig. 5A and
supplemental Fig. S3). LD spectra for preformed anti-cBt:cBt
complexes at different ratios were also negligible without spe-
cific binding or orientation, but revealed shape similarities with
the spectra for cBt implying competing interactions of cBt for
anti-cBt andmembrane surfaces (Fig. 5A and supplemental Fig.
S3). Further support for this conclusion comes from solid-state
NMR studies.
Fig. 5B shows static 2H spectra of anionic membranes with
chain-deuterated lipids (DMPC-d54) in the absence and pres-
ence of the peptides. Spectra for the membrane alone showed
maximum and minimum splittings of 28 and 4.9 kHz, respec-
tively. Intermediate peaks that correspond to CD2 groups along
the fatty acid acyl chains were well resolved. On addition of cBt,
no individual peaks could be resolved, suggesting that the pep-
tide interacts with and disorders the lipid molecules along the
length of the acyl chains. Inmarked contrast, the innermost and
outermost splittings for anti-cBt:cBt were consistent with the
lipid only spectrum, suggesting that anti-cBt prevents cBt from
disrupting the lipids. In all of the spectra, the innermost split-
ting corresponding to the CD3 groups on the ends of the acyl
chains was apparent, implying that the lipid termini remained
buried within the lipid bilayer, which together with that there
were no dominant peaks observed at 0 kHz suggests that
micellization did not take place (Fig. 5B). The observations are
consistent with the CD and LD data in that cBt folds onto ani-
onic membranes and binds with its antagonist through cooper-
ative interactions that interfere with membrane binding (35).
Cecropin Assembly in Bacterial Culture—The results dis-
cussed so far support the formation of anti-cBt:cBt complexes
that can exist in dynamic membrane environments. However,
to be competitive under equilibrium conditions the interac-
tions are likely to require anti-cBt in excess. In physiological
terms, this is consistent with that AMPs must respond to
microbial challenge within their proteolytic life time (i.e. min-
utes) and that inhibitory effects on antimicrobial activity should
become apparent within the same time scale.
Toprobe this,weperformedstain-deadassaysusinga log-phase
planktonic culture of S. aureus. MICs against the bacterium were
at 15–30 M ranges (25 M, Table 1), at which anti-cBt:cBt were
stable up to 70 °C (Fig. 2H). In these assays the fluorescence emis-
sion of propidium iodide used as a dead cellmarkerwasmeasured
after peptide addition as a function of time (Fig. 6).
To directly assess the inhibition of cBt by anti-cBt the total
number of cells lysed by cBt at the MIC after 1 h was taken as
100% killing rates. Thus, in the first 30 min killing rates for cB
and cBt were60 and40%, respectively (Fig. 6, A and B). No
effects observed for anti-cBt at concentrations 	100 M, and
marginal killing rates (10%) at higher concentrations (	250
FIGURE 5. Cecropin folding in anionic membranes. A, LD spectra for cBt
(dotted line), anti-cBt (bold line), cBt added to anti-cBt (dashed line) and pre-
formed anti-cBt:cBt (dot-dashed line). Lipid-peptide ratio was 100:1 (20 M
peptide), pH7.4, room temperature.Arrowspoint to-* andn-* electronic
transition bands. B, solid-state NMR spectra for blank (no peptide, black), cBt
(red), and anti-cBt:cBt (blue). Lipid-peptide ratio was 25:1, pH 7.4, room tem-
perature. Vertical dashed lines are to assist comparison between the inner-
most and outermost splittings of the three spectra.
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M) were consistent with the medium cytotoxicity of the pep-
tide at hemolytic concentrations (Table 1). For anti-cBt:cBt at
5–10:1 molar ratios a continuous lag-phase in killing rates of

10%was observed over the first 40min of incubation (Fig. 6,A
and B). The effect then became less apparent with gradual
exponential increases in killing rates up to 60% after 60 min
accounting for 40% decreases in the activity of cBt. The optical
density measurements of bulk culture overnight (MIC assays)
at 5–10:1 ratios gave the visible growth of S. aureus which was
comparable with that of the bacterium without peptide (Fig.
6C). In contrast, lower anti-cBt:cBt ratios (
5:1) imposed no
inhibition on the antimicrobial activity of cBt (Fig. 5C). E. coli
and P. aeruginosa that were found to bemore susceptible to cBt
(Table 1) gave varied and irreproducible MIC differences
between cBt and anti-cBt:cBt. Because optical densitymeasure-
ments take no account of changes at the cellular level we sought
additional evidence from Gram stain assays for these strains.
E. coli and P. aeruginosa incubated with peptide for 16 h were
Gram-stained and imaged by optical microscopy (Fig. 7A and
supplemental Fig. S4). Nearly complete inhibition of cell
growth by cBt was apparent for both strains. No obvious effects
were found for anti-cBt and anti-cBt:cBt samples (10:1) in
which cell populations were remarkably similar for both strains
(Fig. 7, A and B). Round and blue-stained spheroplasts, partic-
ularly for P. aeruginosa, were observed for cBt and anti-cBt:cBt
samples, but not in anti-cBt samples. This is consistent with
spheroplast-forming activities of cell wall or membrane-active
antibiotics (36), which implies that anti-cBt:cBt may retain
residual antimicrobial activity of cBt giving rise to cell wall defi-
cient-forms (Fig. 7).
DISCUSSION
The results prompt several conclusions. Firstly, anti-antimi-
crobial activity may occur at a microscopic level, which is not
necessarily detected by changes in optical density. Second, the
5–10:1 ratios of anti-AMP to AMP give detectable anti-antimi-
crobial effects. Third, coiled-coil stability, which directly links
to primary structure, determines all of these points. Indeed,
other antimicrobial sequences that are biologically and struc-
turally similar to cB and b27 are shorter. This decreases the
probability of shorter antagonists and their assemblies with
AMPs.Magainin 2 (m2) can serve as an example. The peptide is
a 23-mer with one G(X)4G motif, which thus can represent a
shorter version of cB. Although it was possible to assign a
coiled-coil template in the sequence our attempts to find an
efficient antagonist were unsuccessful (supplemental Figs. S5
and S6). Furthermore, mutations used to generate suitable
magainin templates significantly compromised membrane
binding (supplemental Fig. S6). This lack in sequence plasticity
may not come as a surprise if one considers that shorter anti-
microbial helices may aim at minimizing the possibility of co-
folding with potential antagonists, which in turn are challenged
to produce stronger binders. Such a competition is pre-defined
in native AMPs which contain the patterns of both antimicro-
bial helices and coiled coils. The former is thus designed to
prevail in membrane environments but can become “frus-
trated” by a competitive trigger, an antagonist, which gives way
to the latter.
Antimicrobial peptides are being considered as new drug
candidates in the post-antibiotic era (7). Their clinical
potential is largely attributed to that widespread microbial
resistance against them has yet to emerge (10, 37, 38). In this
context, it is plausible to suggest that antagonistic sequences
secreted by bacterial cells or expressed on their surfaces may
elicit anti-antimicrobial responses. Although this remains to
be shown in nature, this report, to the best of our knowledge,
provides the first example of peptide sequences capable of
FIGURE6.Stain-deadS. aureus cells.A, percentageof stain-deadcells as a functionof time for cB (100M, red squares), cBt (25M,green triangles), anti-cBt (250
M, purple crosses), and anti-cBt:cBt (125:25 M, blue diamonds). B, confocal microscopy images of cells stained with propidium iodide after incubation with
corresponding peptide. C, absorbances measured overnight at 600 nm for the bacterium incubated with anti-cBt:cBt at different ratios (black pillars), for the
bacterium without peptide and for the culture medium only (gray pillars). Error bars, S.D.
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antagonistic responses to the action of host defense peptides.
Specifically, the combination of experimental and computa-
tional approaches confirms a coiled-coil-mediated antagonistic
mechanism which is consistent with the functional basis of
antimicrobial peptides as local and short contact time immune
regulators.
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